Valuation: Novonesis A/S

Market Cap 205B 30.44B 27.43B 25.35B 22.91B 43.35B 2,855B 44.42B 304B 121B 1,529B 114B 112B 4,866B P/E 2026 *
36x
P/E 2027 * 32x
Enterprise Value 225B 33.42B 30.12B 27.83B 25.16B 47.59B 3,134B 48.77B 333B 133B 1,679B 125B 123B 5,342B EV / Sales 2026 *
6.73x
EV / Sales 2027 * 6.21x
Free-Float
74.08%
Yield 2026 *
1.66%
Yield 2027 * 1.85%
1 day+2.79%
1 week-1.46%
Current month-2.06%
1 month+3.86%
3 months+8.07%
6 months+20.70%
Current year+10.96%
1 week 439.8
Extreme 439.8
484.7
1 month 433.6
Extreme 433.6
484.7
Current year 336.8
Extreme 336.8
484.7
1 year 336.8
Extreme 336.8
484.7
3 years 336.8
Extreme 336.8
489.4
5 years 274.6
Extreme 274.6
545.8
10 years 220.7
Extreme 220.7
545.8
Date Insider Type Main position Quantity % Market Cap. Importance
21/11/25 Buy

Director

2,500 0.0006%
21/11/25 Buy

Director

2,500 0.0006%
07/11/25 Buy

Head of Human Resources

380 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-1.46%+6.35%+29.95% 30.59B
-0.06%-2.87%+16.76%+70.93% 85.83B
+0.89%+0.27%+18.86%+28.31% 45.21B
+0.13%+4.21%+23.65%-14.58% 37.66B
+0.27%+6.28%+21.26%+23.10% 36.86B
+1.59%+1.56%+4.82%+24.42% 26.13B
+1.20%-0.76%+51.89%+37.56% 23.66B
+0.41%+4.70%+30.20%-23.24% 20.79B
+1.53%-4.12%+6.75%+14.72% 15.55B
+1.58%-0.42%+31.71%-1.04% 14.33B
Average +1.04%+1.78%+21.22%+19.01% 34B
Weighted average by Cap. +0.78%+1.85%+19.91%+29.25%

Financials

2026 *2027 *
Net sales 33.47B 4.97B 4.48B 4.14B 3.74B 7.07B 466B 7.25B 49.57B 19.76B 249B 18.64B 18.24B 794B 36.02B 5.35B 4.82B 4.45B 4.02B 7.61B 501B 7.8B 53.35B 21.26B 269B 20.06B 19.64B 855B
Net income 5.52B 820M 739M 682M 617M 1.17B 76.86B 1.2B 8.18B 3.26B 41.17B 3.08B 3.01B 131B 6.39B 949M 855M 790M 714M 1.35B 88.99B 1.38B 9.47B 3.77B 47.66B 3.56B 3.49B 152B
Net Debt 20.07B 2.98B 2.69B 2.48B 2.24B 4.24B 279B 4.35B 29.73B 11.85B 150B 11.18B 10.94B 476B 18.69B 2.77B 2.5B 2.31B 2.09B 3.95B 260B 4.05B 27.69B 11.04B 139B 10.41B 10.19B 444B
Projected Income Statement - Annual - Novonesis A/S
Logo Novonesis A/S
Novonesis A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - agriculture, bioenergy and animal feed industries (35.8%); - food industries (33%); - cleaning and household care products industries (19.3%); - human nutritional health industries (11.9%). Net sales are geographically distributed as follows: Denmark (1.1%), Europe/Middle East/Africa (34.6%), North America (32%), Asia/Pacific (18.7%), and Latin America (13.6%).
Employees
11,098
Date Price Change Volume
11/11/26 DKK 452.50 +2.79% 634,847
10/11/26 DKK 440.20 -3.42% 1,129,833
09/11/26 DKK 455.80 -0.91% 679,177
06/11/26 DKK 460.00 -4.15% 905,267
05/11/26 DKK 479.90 +4.51% 1,112,390
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Novonesis A/S
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
440.20DKK
Average target price
509.33DKK
Spread / Average Target
+15.70%
  1. Stock Market
  2. Stocks
  3. NSIS B Stock